Vabysmo for Diabetic Macular Edema User Reviews
Vabysmo has an average rating of 10.0 out of 10 from a total of 4 reviews for the treatment of Diabetic Macular Edema. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
- marco...
- Taken for 1 to 6 months
- August 1, 2023
"Vabysmo, I'm on my second dose. It seems to be helping my eyes see better. The cost of this drug is way over $1,200 per dose though. But it is the best out there for your eyes."
- marki...
- Taken for 1 to 6 months
- August 12, 2023
"It works and I actually didn't need another shot at my last eye appointment. Very thankful."
Frequently asked questions
- MLM
- Taken for 1 to 2 years
- May 1, 2024
"Worked in reducing edema. Site is stable. Encouraging results."
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about Vabysmo (faricimab)
- Compare alternatives
- Pricing & coupons
- Reviews (17)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
"After 3 years of regular Eylea injections, with only a few weeks of subsequent short-lived marginal improvement in vision following treatment, I was converted to Vabysmo in January 2023. After the first injection, improved and maintained vision was clearly noticeable, and after 4 treatments at 4-week intervals, retinal scans showed a dramatic, almost complete elimination of retinal swelling. For the first time in 17 years, almost perfect (84/85) vision! I am now beginning a 12-week interval before the next treatment. Side effects: I am beginning to suspect that a significant change in my bowel movements might be related to the new treatment. I will be looking out for any changes as a consequence of an extended period between injections. In summary, an exceptional result so far, especially after a long period of poor sight in the one affected eye."